The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Renin-Angiotensin-Aldosterone System and Progression of Renal Disease
Abstract
Inhibition of the renin-angiotensin-aldosterone system (RAAS) is one of the most powerful maneuvers to slow progression of renal disease. Angiotensin II (AngII) has emerged in the past decade as a multifunctional cytokine that exhibits many nonhemodynamic properties, such as acting as a growth factor and profibrogenic cytokine, and even having proinflammatory properties. Many of these deleterious functions are mediated by other factors, such as TGF-beta and chemoattractants that are induced in the kidney by AngII. Moreover, understanding of the RAAS has become much more complex in recent years with the identification of novel peptides (e.g., AngIV) that could bind to specific receptors, elucidating deleterious effects, and non-angiotensin-converting enzyme (ACE)-mediated generation of AngII. The ability of renal cells to produce AngII in a concentration that is much higher than what is found in the systemic circulation and the observation that aldosterone may be engaged directly in profibrogenic processes independent of hypertension have added to the complexity of the RAAS. Even renin has now been identified to have a "life on its own" and mediates profibrotic effects via binding to specific receptors. Finally, drugs that are used to block the RAAS, such as ACE inhibitors or certain AngII type 1 receptor antagonists, may have properties on cells independent of AngII (ACE inhibitor-mediated outside-inside signaling and peroxisome proliferator-activated receptor-gamma stimulatory effects of certain sartanes). Although blockade of the RAAS with ACE inhibitors, AngII type 1 receptor antagonists, or the combination of both should be part of every strategy to slow progression of renal disease, a better understanding of the novel aspects of the RAAS should contribute to the development of innovative strategies not only to completely halt progression but also to induce regression of human renal disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
Dragun, D., Müller, D. N., Bräsen, J. H., Fritsche, L., Nieminen-Kelhä, M., Dechend, R., Kintscher, U., Rudolph, B., Hoebeke, J., Eckert, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa035717 · Cited by 868
Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes
Remuzzi, G. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27699 · Cited by 618
From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease
Wolf, G., Chen, S., & Ziyadeh, F. N. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1626 · Cited by 565
Self-citationEvidence That the Angiotensin IV (AT4) Receptor Is the Enzyme Insulin-regulated Aminopeptidase
Albiston, A. L., McDowall, S. G., Matsacos, D., Sim, P., Clune, E., Mustafa, T., Lee, J., Mendelsohn, F. A. O., Simpson, R. J., Connolly, L. M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100512200 · Cited by 461
Huang, Y., Wongamorntham, S., Kasting, J., McQuillan, D., Owens, R. T., Yu, L., Noble, N. A., & Border, W. (2006) · Kidney International · doi:10.1038/sj.ki.5000011 · Cited by 423
Renal albumin absorption in physiology and pathology
Birn, H., & Christensen, E. I. (2006) · Kidney International · doi:10.1038/sj.ki.5000141 · Cited by 381
Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy
Tikellis, C., Johnston, C. I., Forbes, J. M., Burns, W. C., Burrell, L. M., Risvanis, J., & Cooper, M. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000060689.38912.cb · Cited by 350
Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach
Lautrette, A., Li, S., Alili, R., Sunnarborg, S. W., Burtin, M., Lee, D. C., Friedlander, G., & Terzi, F. (2005) · Nature Medicine · doi:10.1038/nm1275 · Cited by 343
Rodríguez-Vita, J., Sánchez-López, E., Esteban, V., Rupérez, M., Egido, J., & Ruiz-Ortega, M. (2005) · Circulation · doi:10.1161/01.cir.0000165133.84978.e2 · Cited by 327
Durvasula, R. V., Petermann, A. T., Hiromura, K., Blonski, M., Pippin, J., Mundel, P., Pichler, R., Griffin, S., Couser, W. G., & Shankland, S. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00362.x · Cited by 313
Wolf, G., & Ritz, E. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00145.x · Cited by 289
Self-citationSchupp, M., Clemenz, M., Gineste, R., Witt, H., Janke, J., Helleboid, S., Hennuyer, N., Ruiz, P., Unger, T., Staels, B., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3442 · Cited by 274
Angiotensin-Converting Enzyme II in the Heart and the Kidney
Danilczyk, U., & Penninger, J. M. (2006) · Circulation Research · doi:10.1161/01.res.0000205761.22353.5f · Cited by 269
Renal Interstitial Fluid Concentrations of Angiotensins I and II in Anesthetized Rats
Nishiyama, A., Seth, D. M., & Navar, L. G. (2002) · Hypertension · doi:10.1161/hy0102.100536 · Cited by 230
Huang, X. R., Chen, W. Y., Truong, L. D., & Lan, H. Y. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000071512.93927.4e · Cited by 228
Wolf, G., Wenzel, U., Burns, K. D., Harris, R. C., Stahl, R. A. K., & Thaiss, F. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00365.x · Cited by 226
Self-citationAldosterone Potentiates Angiotensin II–Induced Signaling in Vascular Smooth Muscle Cells
Mazak, I., Fiebeler, A., Muller, D. N., Park, J.-K., Shagdarsuren, E., Lindschau, C., Dechend, R., Viedt, C., Pilz, B., Haller, H., et al. (2004) · Circulation · doi:10.1161/01.cir.0000131860.80444.ab · Cited by 218
The Renin-Angiotensin System and Progression of Renal Disease: From Hemodynamics to Cell Biology
Wolf, G., Butzmann, U., & Wenzel, U. O. (2002) · Nephron Physiology · doi:10.1159/000066656 · Cited by 211
Self-citationEts-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling
Zhan, Y. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24403 · Cited by 209
AbdAlla, S., Lother, H., Langer, A., el Faramawy, Y., & Quitterer, U. (2004) · Cell · doi:10.1016/j.cell.2004.10.006 · Cited by 205
Long-Term Regulation of ENaC Expression in Kidney by Angiotensin II
Beutler, K. T., Masilamani, S., Turban, S., Nielsen, J., Brooks, H. L., Ageloff, S., Fenton, R. A., Packer, R. K., & Knepper, M. A. (2003) · Hypertension · doi:10.1161/01.hyp.0000066129.12106.e2 · Cited by 170
Angiotensin-Converting Enzyme Inhibitors: A New Mechanism of Action
Peng, H., Carretero, O. A., Vuljaj, N., Liao, T.-D., Motivala, A., Peterson, E. L., & Rhaleb, N.-E. (2005) · Circulation · doi:10.1161/circulationaha.104.528695 · Cited by 160
Renal and vascular hypertension-induced inflammation: role of angiotensin II
Ruiz-Ortega, M., Esteban, V., Rupérez, M., Sánchez-López, E., Rodríguez-Vita, J., Carvajal, G., & Egido, J. (2006) · Current Opinion in Nephrology and Hypertension · doi:10.1097/01.mnh.0000203190.34643.d4 · Cited by 158
Huang, W., Gallois, Y., Bouby, N., Bruneval, P., Heudes, D., Belair, M., Krege, J. H., Meneton, P., Marre, M., Smithies, O., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231476798 · Cited by 151
Update on the role of the AT2 receptor
Carey, R. M. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200501000-00011 · Cited by 133
Thway, T. M., Shlykov, S. G., Day, M.-C., et al. (2004) · Circulation · doi:10.1161/01.cir.0000142855.68398.3a · Cited by 129
Nishiyama, A., Seth, D. M., & Navar, L. G. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000026610.48842.cb · Cited by 103
TGF-β impairs renal autoregulation via generation of ROS
Sharma, K., Cook, A. K., Smith, M. P. W., Valancius, C., & Inscho, E. W. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00345.2004 · Cited by 103
Chen, S., Lee, J. S., de la Cruz, M. D. C. I., Wang, A., Izquierdo‐Lahuerta, A., Gandhi, N. K., Danesh, F. R., Wolf, G., & Ziyadeh, F. N. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh837 · Cited by 97
Self-citationLink between Angiotensin II and TGF-β in the Kidney
Wolf, G. (1998) · Mineral and Electrolyte Metabolism · doi:10.1159/000057367 · Cited by 92
Self-citationAngiotensin II Upregulates Toll-Like Receptor 4 on Mesangial Cells
Wolf, G., Bohlender, J. M., Bondeva, T., Roger, T., Thaiss, F., & Wenzel, U. O. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005070699 · Cited by 91
Self-citationAngiotensin II and Cell Cycle Regulation
Wolf, G., & Wenzel, U. O. (2004) · Hypertension · doi:10.1161/01.hyp.0000120963.09029.ca · Cited by 85
Self-citationThe tissue renin–angiotensin system and intracellular signalling
Fleming, I., Kohlstedt, K., & Busse, R. (2005) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000196146.65330.ea · Cited by 68
Nishiyama, A., & Abe, Y. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fmj05003x3 · Cited by 64
Caruso‐Neves, C., Kwon, S., & Guggino, W. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507255102 · Cited by 64
Halting the Progression of Chronic Nephropathy
Campbell, R. C., Ruggenenti, P. L., & Remuzzi, G. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032522.29672.0a · Cited by 53
N-Acetylcysteine Decreases Angiotensin II Receptor Binding in Vascular Smooth Muscle Cells
Ullian, M. E., Gelasco, A. K., Fitzgibbon, W. R., Beck, C., & Morinelli, T. A. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004060458 · Cited by 50
Wolf, G., Schroeder, R., & Stahl, R. A. K. (2004) · American Journal of Nephrology · doi:10.1159/000080086 · Cited by 49
Self-citationBrinkkoetter, P.-T., Holtgrefe, S., van der Woude, F. J., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000102476.50041.44 · Cited by 41
Jankowski, V., Vanholder, R. C., van der Giet, M., Henning, L., Tölle, M., Schönfelder, G., Krakow, A. M., Karadogan, S., Gustavsson, N., Gobom, J., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000177436.09733.d4 · Cited by 29
Matsumoto, K., Morishita, R., Tomita, N., Moriguchi, A., Komai, N., Aoki, M., Matsumoto, K., Nakamura, T., Higaki, J., & Ogihara, T. (2003) · Heart and Vessels · doi:10.1007/s003800300003 · Cited by 20
Angiotensin converting enzyme gene polymorphisms and renal disease
Jardine, A. G., Padmanabhan, N., & Connell, J. (1998) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199805000-00004 · Cited by 20
Cited by
Calcineurin Inhibitor Nephrotoxicity
Naesens, M., Kuypers, D. R. J., & Sarwal, M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04800908 · Cited by 1,489
Mechanisms of Tubulointerstitial Fibrosis
Zeisberg, M., & Neilson, E. G. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080793 · Cited by 868
Angiotensin II revisited: new roles in inflammation, immunology and aging
Benigni, A., Cassis, P., & Remuzzi, G. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000080 · Cited by 757
Nguyen, H. T., Benson, C. B., Bromley, B., Campbell, J. B., Chow, J., Coleman, B., Cooper, C., Crino, J., Darge, K., Anthony Herndon, C. D., et al. (2014) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2014.10.002 · Cited by 561
Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease
Wahba, I. M., & Mak, R. H. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04071206 · Cited by 513
Metadata
- Authors
- Rüster, C., & Wolf, G.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2006-11
- Volume
- 17
- Issue
- 11
- Pages
- 2985-2991
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2097805169
- Cited by
- 463
- References
- 44
- FWCI
- 10.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.